FullHope Biomedical CoROCO:7773 14 Gross Margin % is 76.94% as of Dec. 2025, which is 20% above its 10-year median of 64.31. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 732 Biotechnology companies, FullHope Biomedical Co ranks better than 67.21% on this metric.
ROCO:7773's Gross Margin % is ranked better than 67.21% of 732
companies
in the Biotechnology industry
Industry Median: 60.905
vs ROCO:7773: 75.80
FullHope Biomedical Co had a gross margin of 76.94% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for FullHope Biomedical Co was 0.00% per year.
FullHope Biomedical Co (ROCO:7773) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
FullHope Biomedical Co had a gross margin of 76.94% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
FullHope Biomedical Co Gross Margin % Related Terms
FullHope Biomedical Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for FullHope Biomedical Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7773 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, FullHope Biomedical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FullHope Biomedical Co Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where FullHope Biomedical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
FullHope Biomedical Co (ROCO:7773) has a Gross Margin % of 76.94% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on FullHope Biomedical Co and its competitors. This is 20% above median its historical median of 64.31. Over the past decade, FullHope Biomedical Co's Gross Margin % has ranged from 52.28 to 75.80. According to the industry distribution chart, FullHope Biomedical Co ranks #240 out of 732 companies in the Biotechnology industry, placing it in the top 32.8%.
Is FullHope Biomedical Co's Gross Margin % too high?
FullHope Biomedical Co's current Gross Margin % of 76.94% is 20% above median its 10-year median of 64.31. Over the past 10 years, this metric has ranged from a low of 52.28 to a high of 75.80. The Biotechnology industry median Gross Margin % is 60.91. FullHope Biomedical Co's value of 76.94% is 26.3% above this industry median. Based on the distribution chart, FullHope Biomedical Co ranks #240 out of 732 companies in the Biotechnology industry, which is above the industry midpoint. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FullHope Biomedical Co ranks #240 out of 732 companies for Gross Margin %. This puts FullHope Biomedical Co in the upper half of its industry. The industry median Gross Margin % is 60.91. FullHope Biomedical Co's value of 76.94% is 26.3% above this benchmark. Historically, FullHope Biomedical Co's own Gross Margin % has ranged from 52.28 to 75.80 over the past decade. While the company's 10-year median is 64.31 vs. the industry median of 60.91, FullHope Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. FullHope Biomedical Co's current Gross Margin % of 76.94% is 26.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on FullHope Biomedical Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FullHope Biomedical Co's current Gross Margin % is 76.94%, which is 20% above median its own 10-year median of 64.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Gross Margin % of 76.94%. The current Gross Margin % is 76.94%, which is 20% above median its 10-year median of 64.31 and 26.3% above the Biotechnology industry median of 60.91. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Gross Margin % is 76.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score
Get the complete analysis for ROCO:7773
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7773 has been successfully added to your 